Lundbeck CEO's pay cut in half in 2020

Lundbeck CEO Deborah Dunsire's salary has been more than halved in 2020, compared with the year before, because Lundbeck gave much higher compensation for Danish taxes on her income in 2019.

Photo: Gregers Tycho/Ritzau/Ritzau Scanpix

Danish pharmaceutical company Lundbeck's top management was rewarded with decent pay raises in 2020, which late in the year cast off significantly more profits than analysts forecast – and more, even, than the same period in the year before.

Lundbeck's CEO Deborah Dunsire's salary, however, significantly changed from one year to the next: In 2020, less than half her 2019 pay went into her bank account.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs